158 related articles for article (PubMed ID: 9748106)
1. Intracerebroventricular glucagon-like peptide-1 (7-36) amide inhibits sham feeding in rats without eliciting satiety.
Asarian L; Corp ES; Hrupka B; Geary N
Physiol Behav; 1998 Jun; 64(3):367-72. PubMed ID: 9748106
[TBL] [Abstract][Full Text] [Related]
2. Intravenous infusion of glucagon-like peptide-1 potently inhibits food intake, sham feeding, and gastric emptying in rats.
Chelikani PK; Haver AC; Reidelberger RD
Am J Physiol Regul Integr Comp Physiol; 2005 Jun; 288(6):R1695-706. PubMed ID: 15718384
[TBL] [Abstract][Full Text] [Related]
3. Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats.
Schick RR; Zimmermann JP; vorm Walde T; Schusdziarra V
Am J Physiol Regul Integr Comp Physiol; 2003 Jun; 284(6):R1427-35. PubMed ID: 12776726
[TBL] [Abstract][Full Text] [Related]
4. Colocalization of glucagon-like peptide-1 (GLP-1) receptors, glucose transporter GLUT-2, and glucokinase mRNAs in rat hypothalamic cells: evidence for a role of GLP-1 receptor agonists as an inhibitory signal for food and water intake.
Navarro M; Rodriquez de Fonseca F; Alvarez E; Chowen JA; Zueco JA; Gomez R; Eng J; Blázquez E
J Neurochem; 1996 Nov; 67(5):1982-91. PubMed ID: 8863504
[TBL] [Abstract][Full Text] [Related]
5. PVN infusion of GLP-1-(7-36) amide suppresses feeding but does not induce aversion or alter locomotion in rats.
McMahon LR; Wellman PJ
Am J Physiol; 1998 Jan; 274(1):R23-9. PubMed ID: 9458894
[TBL] [Abstract][Full Text] [Related]
6. A role for glucagon-like peptide-1 in the central regulation of feeding.
Turton MD; O'Shea D; Gunn I; Beak SA; Edwards CM; Meeran K; Choi SJ; Taylor GM; Heath MM; Lambert PD; Wilding JP; Smith DM; Ghatei MA; Herbert J; Bloom SR
Nature; 1996 Jan; 379(6560):69-72. PubMed ID: 8538742
[TBL] [Abstract][Full Text] [Related]
7. Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms.
Rüttimann EB; Arnold M; Hillebrand JJ; Geary N; Langhans W
Endocrinology; 2009 Mar; 150(3):1174-81. PubMed ID: 18948395
[TBL] [Abstract][Full Text] [Related]
8. Effect of chronic central administration of glucagon-like peptide-1 (7-36) amide on food consumption and body weight in normal and obese rats.
Davis HR; Mullins DE; Pines JM; Hoos LM; France CF; Compton DS; Graziano MP; Sybertz EJ; Strader CD; Van Heek M
Obes Res; 1998 Mar; 6(2):147-56. PubMed ID: 9545022
[TBL] [Abstract][Full Text] [Related]
9. Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.
Tang-Christensen M; Larsen PJ; Göke R; Fink-Jensen A; Jessop DS; Møller M; Sheikh SP
Am J Physiol; 1996 Oct; 271(4 Pt 2):R848-56. PubMed ID: 8897973
[TBL] [Abstract][Full Text] [Related]
10. Peptide YY3-36 and glucagon-like peptide-17-36 inhibit food intake additively.
Neary NM; Small CJ; Druce MR; Park AJ; Ellis SM; Semjonous NM; Dakin CL; Filipsson K; Wang F; Kent AS; Frost GS; Ghatei MA; Bloom SR
Endocrinology; 2005 Dec; 146(12):5120-7. PubMed ID: 16150917
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 (7-36) amide administered into the third cerebroventricle inhibits water intake in rats.
Wang T; Edwards GL; Baile CA
Proc Soc Exp Biol Med; 1998 Oct; 219(1):85-91. PubMed ID: 9751227
[TBL] [Abstract][Full Text] [Related]
12. A functional role for central glucagon-like peptide-1 receptors in lithium chloride-induced anorexia.
Rinaman L
Am J Physiol; 1999 Nov; 277(5):R1537-40. PubMed ID: 10564228
[TBL] [Abstract][Full Text] [Related]
13. Effects of various N-terminal fragments of glucagon-like peptide-1(7-36) on food intake in the neonatal chick.
Furuse M; Bungo T; Shimojo M; Masuda Y; Saito N; Hasegawa S; Sugahara K
Brain Res; 1998 Oct; 807(1-2):214-7. PubMed ID: 9757042
[TBL] [Abstract][Full Text] [Related]
14. Central administration of glucagon-like peptide-1 activates hypothalamic neuroendocrine neurons in the rat.
Larsen PJ; Tang-Christensen M; Jessop DS
Endocrinology; 1997 Oct; 138(10):4445-55. PubMed ID: 9322962
[TBL] [Abstract][Full Text] [Related]
15. GLP-1 antagonism with exendin (9-39) fails to increase spontaneous meal size in rats.
Rüttimann EB; Arnold M; Geary N; Langhans W
Physiol Behav; 2010 Jun; 100(4):291-6. PubMed ID: 20206193
[TBL] [Abstract][Full Text] [Related]
16. Nucleus accumbens GLP-1 receptors influence meal size and palatability.
Dossat AM; Diaz R; Gallo L; Panagos A; Kay K; Williams DL
Am J Physiol Endocrinol Metab; 2013 Jun; 304(12):E1314-20. PubMed ID: 23612998
[TBL] [Abstract][Full Text] [Related]
17. Glucagon-like peptide-1 (7-36) amide: a central regulator of satiety and interoceptive stress.
van Dijk G; Thiele TE
Neuropeptides; 1999 Oct; 33(5):406-14. PubMed ID: 10657518
[TBL] [Abstract][Full Text] [Related]
18. Glucagon-like peptide (GLP-1) is involved in the central modulation of fecal output in rats.
Gülpinar MA; Bozkurt A; Coşkun T; Ulusoy NB; Yegen BC
Am J Physiol Gastrointest Liver Physiol; 2000 Jun; 278(6):G924-9. PubMed ID: 10859222
[TBL] [Abstract][Full Text] [Related]
19. Peripheral versus central effects of glucagon-like peptide-1 receptor agonists on satiety and body weight loss in Zucker obese rats.
Rodriquez de Fonseca F; Navarro M; Alvarez E; Roncero I; Chowen JA; Maestre O; Gómez R; Muñoz RM; Eng J; Blázquez E
Metabolism; 2000 Jun; 49(6):709-17. PubMed ID: 10877194
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of intracerebroventricular glucagon-like peptide-1 on feeding and energy expenditure regulation.
Hwa JJ; Ghibaudi L; Williams P; Witten MB; Tedesco R; Strader CD
Peptides; 1998; 19(5):869-75. PubMed ID: 9663452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
